[Two cases of advanced hepatocellular carcinoma with portal vein tumor thrombus responding to transcatheter arterial infusion chemotherapy using cisplatin].
We report two cases of advanced hepatocellular carcinoma( HCC) with a portal vein tumor thrombus (PVTT) responding to transcatheter arterial infusion chemotherapy (TAI) using cisplatin (CDDP). Case 1: A 65-year-old male patient was diagnosed with unresectable multiple HCCs. After 5 courses of transcatheter arterial chemoembolization (TACE), the tumor became markedly enlarged, and a PVTT (Vp2) and lymph node metastasis were noted. TAI was conducted as the second- line chemotherapy, and the liver tumor, PVTT, and lymph node metastasis shrank. The clinical response was rated as a partial response (PR). Case 2: A 72-year-old female patient was diagnosed with single HCC. After a course of TACE, the tumor became markedly enlarged and was accompanied by a PVTT (Vp4). TAI was performed as the second-line chemotherapy, and the liver tumor and PVTT significantly shrank. The clinical response was also rated as a PR. TAI using CDDP as the second-line chemotherapy for advanced HCC is a promising treatment likely to contribute to the improvement of the patient's prognosis.
Usui
Takebumi
T
Department of Surgery, Tokyo Women's Medical University, Medical Center East.
Shiozawa
Shunichi
S
Kim
Dal Ho
DH
Tsuchiya
Akira
A
Masuda
Toshio
T
Inose
Satoshi
S
Aizawa
Masaki
M
Yoshimatsu
Kazuhiko
K
Katsube
Takao
T
Naritaka
Yoshihiko
Y
Ogawa
Kenji
K
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology*; D002404:Catheterization; D002945:Cisplatin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D009360:Neoplastic Cells, Circulating / Q000187:drug effects*; D011169:Portal Vein
D000970:Antineoplastic Agents; D002945:Cisplatin